A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Conditions
Obesity · Overweight · Diabetes Mellitus, Type 2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert, Arizona, United States
Contact: Principal Investigator (Sunildat Maheshwari)Synexus Clinical Research US, Inc., Phoenix, Arizona, United States
Contact: Principal Investigator (Shawn Searle)Pima Heart, Tucson, Arizona, United States
Contact: Principal Investigator (Paul Bejarano)Precision Clinical Research, Sunrise, Florida, United States
Contact: Principal Investigator (Jeffrey Schneider)SKY Clinical Research Network Group-Brown, Atlanta, Georgia, United States
Contact: Principal Investigator (Tamara Brown)Teak Research Consults, Lawrenceville, Georgia, United States
Contact: Principal Investigator (Kamar Alabi)AGILE Clinical Research Trials, LLC, Sandy Springs, Georgia, United States
Contact: Principal Investigator (Vasundhara Cheekati)Pivotal Research Solutions, Stonecrest, Georgia, United States
Contact: Principal Investigator (Rabahuddin Syed)Rophe Adult and Pediatric Medicine/SKYCRNG, Union City, Georgia, United States
Contact: Principal Investigator (Dwight Blake)Vector Clinical Trials, Las Vegas, Nevada, United States
Contact: Principal Investigator (Cornell Calinescu)Premier Research, Trenton, New Jersey, United States
Contact: Principal Investigator (Herbert Conaway)PriMED Clinical Research, Dayton, Ohio, United States
Contact: Principal Investigator (William Randall)Mercy Family Clinic, Dallas, Texas, United States
Contact: Principal Investigator (Ebere Israel Azubuike, MD)Velocity Clinical Research, Dallas, Dallas, Texas, United States
Contact: Principal Investigator (Dan Lender)Biopharma Informatic, LLC, Houston, Texas, United States
Contact: Principal Investigator (Agadadash Kuliev)PlanIt Research, PLLC, Houston, Texas, United States
Contact: Principal Investigator (Prashant Koshy)Research Physicians Network, LLC, Houston, Texas, United States
Contact: Principal Investigator (Jawad Sarwar, MD)Aavon Clinical Trials, Richmond, Texas, United States
Contact: Principal Investigator (Namrata Dass)Consano Clinical Research, LLC, Shavano Park, Texas, United States
Contact: Principal Investigator (Michelle Welch)Texas Valley Clinical Research, Weslaco, Texas, United States
Contact: Principal Investigator (Eduardo Luna)Kalo Clinical Research, West Valley City, Utah, United States
Contact: Principal Investigator (Cuper Martinez)Eastern Virginia Medical School (EVMS) Medical Group, Norfolk, Virginia, United States
Contact: Principal Investigator (Elias Siraj)Clinical Research Partners, LLC, Richmond, Virginia, United States
Contact: Principal Investigator (Robert Call)Northwest Clinical Research Center, Bellevue, Washington, United States
Contact: Principal Investigator (Jeena Vaid)Rainier Clinical Research Center, Renton, Washington, United States
Contact: Principal Investigator (Frances Broyles)Universal Research Group, Tacoma, Washington, United States
Contact: Principal Investigator (Sabrina Benjamin)Centro de Investigaciones Metabólicas (CINME), Buenos Aires, Argentina
Contact: Principal Investigator (Federico Perez Manghi)CENUDIAB, Buenos Aires, Argentina
Contact: Principal Investigator (Alejandra Oviedo)CEDIC, CABA, Argentina
Contact: Principal Investigator (Elizabeth Gelersztein)Instituto de Investigaciones Clínicas Córdoba, Córdoba, Argentina
Contact: Principal Investigator (Ines Bartolacci)Clínica Universitaria Reina Fabiola, Córdoba, Argentina
Contact: Principal Investigator (Silvina Dominguez Matheu)Go Centro Medico San Nicolás, San Nicolás, Argentina
Contact: Principal Investigator (Paulina Lanchiotti)Emeritus Research, Botany, Australia
Contact: Principal Investigator (Paul Bird)Core Research Group, Brisbane, Australia
Contact: Principal Investigator (David Colquhoun)Emeritus Research, Camberwell, Australia
Contact: Principal Investigator (Sam Francis)Cornerstone Dermatology, Coorparoo, Australia
Contact: Principal Investigator (Young Jin Kim)Momentum Darlinghurst, Darlinghurst, Sydney, Australia
Contact: Principal Investigator (Mark Bloch)CDH Research Institute Pty Ltd, Maroochydore, Australia
Contact: Principal Investigator (Hansjoerg Seltenreich)Momentum Sunshine, Melbourne, Australia
Contact: Principal Investigator (King Cheung)AIM Research, Merewether, Australia
San Juan Bautista School of Medicine - Clinical Research Unit, Caguas, Puerto Rico
Contact: Principal Investigator (Loida Gonzalez-Rodriguez)Mgcendo Llc, San Juan, Puerto Rico
Contact: Principal Investigator (Martha Gomez-Cuellar)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company